Loading...
Thumbnail Image
Publication

The BRG1 chromatin remodeling enzyme links cancer cell metabolism and proliferation

Wu, Qiong
Madany, Pasil A.
Dobson, Jason
Schnabl, Jake M.
Sharma, Soni
Smith, Tara C.
van Wijnen, Andre J.
Stein, Janet L.
Lian, Jane B.
Stein, Gary S.
... show 3 more
Embargo Expiration Date
Link to Full Text
Abstract

Cancer cells reprogram cellular metabolism to meet the demands of growth. Identification of the regulatory machinery that regulates cancer-specific metabolic changes may open new avenues for anti-cancer therapeutics. The epigenetic regulator BRG1 is a catalytic ATPase for some mammalian SWI/SNF chromatin remodeling enzymes. BRG1 is a well-characterized tumor suppressor in some human cancers, but is frequently overexpressed without mutation in other cancers, including breast cancer. Here we demonstrate that BRG1 upregulates de novo lipogenesis and that this is crucial for cancer cell proliferation. Knockdown of BRG1 attenuates lipid synthesis by impairing the transcription of enzymes catalyzing fatty acid and lipid synthesis. Remarkably, exogenous addition of palmitate, the key intermediate in fatty acid synthesis, rescued the cancer cell proliferation defect caused by BRG1 knockdown. Our work suggests that targeting BRG1 to reduce lipid metabolism and, thereby, to reduce proliferation, has promise for epigenetic therapy in triple negative breast cancer.

Source

Oncotarget. 2016 May 20. doi: 10.18632/oncotarget.9505. Link to article on publisher's site

Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.18632/oncotarget.9505
PubMed ID
27223259
Other Identifiers
Notes
Funding and Acknowledgements
Corresponding Author
Related Resources
Related Resources
Repository Citation
Rights
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.